Provided by Tiger Trade Technology Pte. Ltd.

Tenaya Therapeutics Inc

0.9715
+0.08359.40%
Volume:10.19M
Turnover:9.80M
Market Cap:210.34M
PE:-1.30
High:1.04
Open:0.9501
Low:0.8700
Close:0.8880
52wk High:2.35
52wk Low:0.3600
Shares:216.51M
Float Shares:205.84M
Volume Ratio:1.37
T/O Rate:4.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7500
EPS(LYR):-1.3101
ROE:-96.44%
ROA:-49.48%
PB:2.54
PE(LYR):-0.74

Loading ...

Mar 05, 2026

Major Issues Report

Form 8-K - Current report
Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 30, 2026

Major Issues Report

Form 8-K - Current report
Jan 02, 2026

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Nov 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Nov 07, 2025

Major Issues Report

Form 8-K - Current report
Sep 05, 2025

Correspondence

Form CORRESP - Correspondence